| Literature DB >> 34159825 |
Giorgio Fm Cattaneo1, Andrea M Herrmann2,3, Sebastian A Eiden3, Manuela Wieser3, Elias Kellner4, Soroush Doostkam5, Patrick Süß5, Selina Kiefer6, Lisa Fauth6, Christoph J Maurer7, Julia Wolfertz8, Björn Nitzsche2, Michael Büchert8, Tobias Jost8, Gabriele Ihorst9, Jörg Haberstroh10, Christoph Mülling2, Christoph Strecker11, Wolf-Dirk Niesen11, Mukesch J Shah12, Horst Urbach3, Johannes Boltze13, Stephan Meckel3,14.
Abstract
Selective therapeutic hypothermia (TH) showed promising preclinical results as a neuroprotective strategy in acute ischemic stroke. We aimed to assess safety and feasibility of an intracarotid cooling catheter conceived for fast and selective brain cooling during endovascular thrombectomy in an ovine stroke model.Transient middle cerebral artery occlusion (MCAO, 3 h) was performed in 20 sheep. In the hypothermia group (n = 10), selective TH was initiated 20 minutes before recanalization, and was maintained for another 3 h. In the normothermia control group (n = 10), a standard 8 French catheter was used instead. Primary endpoints were intranasal cooling performance (feasibility) plus vessel patency assessed by digital subtraction angiography and carotid artery wall integrity (histopathology, both safety). Secondary endpoints were neurological outcome and infarct volumes.Computed tomography perfusion demonstrated MCA territory hypoperfusion during MCAO in both groups. Intranasal temperature decreased by 1.1 °C/3.1 °C after 10/60 minutes in the TH group and 0.3 °C/0.4 °C in the normothermia group (p < 0.001). Carotid artery and branching vessel patency as well as carotid wall integrity was indifferent between groups. Infarct volumes (p = 0.74) and neurological outcome (p = 0.82) were similar in both groups.Selective TH was feasible and safe. However, a larger number of subjects might be required to demonstrate efficacy.Entities:
Keywords: Acute ischemic stroke; catheter; endovascular stroke therapy; hypothermia; selective brain cooling
Mesh:
Substances:
Year: 2021 PMID: 34159825 PMCID: PMC8756475 DOI: 10.1177/0271678X211024952
Source DB: PubMed Journal: J Cereb Blood Flow Metab ISSN: 0271-678X Impact factor: 6.960